Energy Efficiency, GHG Emissions, Industrial - March 15, 2024
Cardinal Health Receives SBTi Approval
Cardinal Health announced the company received approval by the Science Based Targets initiative (SBTi) for its near-term science-based greenhouse gas (GHG) emissions reduction targets.
"We are committed to reducing our impact on the environment and contributing to a more sustainable world," said Megan Maltenfort, Cardinal Health's VP of Environmental, Social and Governance (ESG), in a statement. "We value our work with SBTi and will continue taking proactive steps to address climate change and to reduce the environmental impact of our products and processes."
Cardinal Health, a distributor of pharmaceuticals, manufacturer and distributor of medical and laboratory products, and provider of performance and data solutions for healthcare facilities, commits to the following science-based targets:
- Lower absolute Scope 1 and 2 GHG emissions 50% by fiscal 2030 from a fiscal 2019 base year and
- 75% of its suppliers by spend, covering purchased goods and services and upstream transportation and distribution, will have science-based targets by fiscal 2028.
These approved targets represent an expansion of the company's current goal of reducing Scope 1 and 2 GHG emissions, as announced in September 2021. The inclusion of Scope 3 emissions from its supply chain has made the goal more ambitious.
"As we work to achieve our targets, we will collaborate with partners along our supply chain to collectively address the impacts of climate change," Maltenfort said.
By the end of fiscal 2023, Cardinal Health lowered its Scope 1 and 2 emissions by 13% from a fiscal 2019 base year. In addition, the company continues to invest in energy efficiency opportunities in its distribution and manufacturing sites and is looking to expand its use of renewable energy across the enterprise.
Read These Related Articles:
Stay Up-To-Date
